3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplasms
1
Adenocarcinoma
1
Interventions
Specimen Handling
483
pembrolizumab
456
Magnetic Resonance Spectroscopy
420
Carboplatin
327
Cyclophosphamide
315
Biopsy
274
Cisplatin
270
Radiotherapy
244
Paclitaxel
229
Gemcitabine
225
Bevacizumab
214
Nivolumab
189
fludarabine
184
venetoclax
174
Drug Therapy
171
Dexamethasone
158
Blood Specimen Collection
158
Oxaliplatin
154
Injections
152
Capecitabine
152
Fluorouracil
145
Docetaxel
144
Radiosurgery
137
Standard of Care
136
Rituximab
125
Pemetrexed
117
durvalumab
114
atezolizumab
110
Leucovorin
110
Radiation
106
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Longitudinal Studies
×
1 year
×
Clear all
NCT07339943
2026-01-14
MicroUSgFLA
University Health Network, Toronto
Phase NA
Recruiting
7 enrolled
NCT06270602
2025-12-22
The ONCOCAMP Study
National Cancer Institute, Naples
Recruiting
15,000 enrolled